Speciociliatine: The Kratom Alkaloid the Science Is Catching Up To

For most of the last decade, speciociliatine was a footnote: the minor alkaloid named in passing right after mitragynine. In 2026 it is suddenly everywhere, with industry explainers and a wave of new analytical work on single, named kratom alkaloids. This is our take, as a lab, on why that shift is happening and what actually matters underneath the noise.

A note up front: this is a chemistry and manufacturing perspective. We describe what speciociliatine is and how it is measured, not what it does for anyone.

What speciociliatine actually is

Speciociliatine is a naturally occurring monoterpenoid indole alkaloid of Mitragyna speciosa, the tree known as kratom. Chemically it is a diastereomer of mitragynine: it carries the same molecular formula, C23H30N2O4, and the same indole scaffold, and differs only in its three-dimensional configuration at the C-3 position.

In the leaf, mitragynine dominates the alkaloid fraction and speciociliatine sits alongside it, often described as one of the more abundant of the minor alkaloids. Its proportion is not fixed; it shifts with leaf maturity, cultivar, and growing region.

Why it was overlooked, and why that is changing

Here is the crux, and the reason the "science just caught up" framing rings true. Because speciociliatine and mitragynine are stereoisomers, you cannot tell them apart by rough composition. Separating and quantifying them is an analytical problem that needs proper chromatography and reference standards.

That capability has matured only recently. Peer-reviewed chromatographic methods now resolve and quantify speciociliatine specifically, separate from mitragynine, across a range of analytical matrices. The molecule did not change. Our ability to see it clearly did.

Our opinion: identity first, hype second

Our position is simple. The market is moving fast to put "speciociliatine" on labels. We think the responsible order of operations is the reverse of the hype cycle: first prove identity with chromatographic separation, then standardize to a known amount, then document it with a third-party Certificate of Analysis on every lot. A stereoisomer you cannot separate is a stereoisomer you cannot stand behind.

That is not a slogan for us; it is the process. Distinguishing diastereomers, standardizing to them, and testing each lot is the hard part, and it is the part a specification sheet and a COA actually prove.

How we approach speciociliatine

We standardize speciociliatine into scored tablets and supply them in bulk, extracted solvent-free and DCM-free from the naturally occurring leaf alkaloids, and tested every lot. For the underlying chemistry, including a side-by-side with mitragynine, see our science hub.